Bristol-Myers Squibb Co (BMY)

Bristol-Myers Squibb faces patent cliff concerns for Plavix, but recent positive clinical trial news and a surge in social media mentions indicate growing investor interest and a potential rebound.

About Bristol-Myers Squibb Co

Bristol-Myers Squibb Co. is a global biopharmaceutical company focused on discovering, developing, manufacturing, and marketing innovative medicines.
Bristol-Myers Squibb Co uses the ticker $BMY for trading. Listed in the Stocks category within the Healthcare sectors.

Price: $60.70

Price 24-Hour Time-Series Raw Data
The stock is trading near its 52-week low due to patent cliff concerns, but recent positive clinical trial news and a surge in social media mentions indicate growing investor interest and a potential rebound.

24-Hour: 1.05% 7-Day: -1.79% 30-Day: 9.92%

1-Year High: $63.10 on 2025-03-10
1-Year Low: $42.60 on 2025-10-29

AltRank: [---]

AltRank Line Chart
AltRank 24-Hour Time-Series Raw Data
Bristol-Myers Squibb Co (BMY) is currently AltRank #688 based on combined combined social and market metrics Daily Average: [---]
[--] Week: [---] [----]
[--] Month: [---] [----]
[--] Months: [---] [----]
[--] Year: [---] +144
1-Year High: [-----] on 2025-07-12
1-Year Low: [--] on 2025-05-17

Galaxy Score: [-----]

Galaxy Score Line Chart
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [--]
[--] Week: [--] +3
[--] Month: [--] +11
[--] Months: [--] +34
[--] Year: [--] +20
1-Year High: [--] on 2025-07-16
1-Year Low: [--] on 2025-05-21

Engagements: [-----] (24h)

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [------]
[--] Week: [-------] -79%
[--] Month: [---------] -42%
[--] Months: [----------] +22%
[--] Year: [----------] +4.10%
1-Year High: [---------] on 2025-12-20
1-Year Low: [-----] on 2026-02-16

Engagements by network (24h): X: [-----] YouTube: [---] Instagram: [--] TikTok: [---] Reddit: [--] News: [---]

Mentions: [---] (24h)

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: [---]
Daily Average: [---]
[--] Week: [-----] -11%
[--] Month: [-----] +99%
[--] Months: [------] -26%
[--] Year: [------] +0.74%
1-Year High: [-----] on 2025-06-27
1-Year Low: [---] on 2025-12-07

Mentions by network (24h): X: [---] YouTube: [--] Instagram: [--] TikTok: [--] Reddit: [--] News: [--]

Creators: [---] (24h)

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
[---] unique social accounts have posts mentioning Bristol-Myers Squibb Co (BMY) in the last [--] hours which is down 6.90% from [---] in the previous [--] hours Daily Average: [---]
[--] Week: [-----] -13%
[--] Month: [-----] +87%
[--] Months: [-----] -43%
[--] Year: [------] +137%
1-Year High: [-----] on 2025-06-27
1-Year Low: [--] on 2025-12-07

The most influential creators that mention Bristol-Myers Squibb Co in the last [--] hours

Creator	Rank	Followers	Posts	Engagements
@HOThomasWPhelps	[--]	[-----]	[--]	[-----]
@DimitryNakhla	[--]	[------]	[--]	[---]
@jobRxiv	[--]	[------]	[--]	[---]
@AvutardaBolsa	[--]	[-----]	[--]	[---]
@semodough	[--]	[-----]	[--]	[---]
@ProfesorDiv	[--]	[-------]	[--]	[---]
@Dykegail	[--]	[--]	[--]	[---]
@doepke_michel	[--]	[-----]	[--]	[---]
@Quantumup1	[--]	[-----]	[--]	[--]
@tunemusicalmoments	[--]	[---------]	[--]	[--]

Sentiment: 85%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: 85%
Daily Average: 77%
[--] Week: 100% +9%
[--] Month: 85% no change
[--] Months: 85% -2%
[--] Year: 85% +24%
1-Year High: 98% on 2025-06-27
1-Year Low: 50% on 2025-05-15

Most Supportive Themes:

Pipeline and Clinical Trial Updates: (40%) Bristol-Myers Squibb is presenting positive results from clinical trials for various treatments.
Partnerships and Collaborations: (30%) Bristol-Myers Squibb is forming strategic alliances and collaborations to advance its drug development pipeline.
Financial Performance and Earnings: (20%) Analysts are anticipating significant updates on Bristol-Myers Squibb's financials and pipeline progress.

Most Critical Themes:

Patent Cliffs and Revenue Concerns: (40%) Bristol-Myers Squibb faces significant revenue challenges due to upcoming patent expirations for key drugs.
Stock Performance and Valuation: (35%) The stock has experienced a significant decline, trading near its 52-week low.
Layoffs and Restructuring: (25%) The company has announced significant layoffs as part of a broader cost-cutting strategy.

Social Dominance: 0.027%

Social Dominance Line Chart
Social Dominance 24-Hour Time-Series Raw Data
Current Value: 0.027%
Daily Average: 0.067%
[--] Week: 0.025% -0.0073%
[--] Month: 0.042% -0.0021%
[--] Months: 0.042% -0.0038%
[--] Year: 0.042% -0.04%
1-Year High: 0.226% on 2025-06-27
1-Year Low: 0.023% on 2025-12-07

Market Dominance: 0.14%

Market Dominance Line Chart
Market Dominance 24-Hour Time-Series Raw Data
Current Value: 0.14%
Daily Average: 0%
1-Year High: 0.24% on 2025-03-12
1-Year Low: 0.103% on 2025-10-29

Market Cap: $123,817,601,264

Market Cap Line Chart
Market Cap 24-Hour Time-Series Raw Data
Current Value: $123,817,601,264
Daily Average: $102,468,373,233
[--] Week: $123,104,835,467 -2.40%
[--] Month: $123,695,412,842 +10%
[--] Months: $123,695,412,842 +26%
[--] Year: $123,695,412,842 +13%
1-Year High: $128,433,949,919 on 2025-03-10
1-Year Low: $86,723,078,950 on 2025-10-29

Top Bristol-Myers Squibb Co News

Top news links shared on social in the last [--] hours

Showing a maximum of [--] news posts without a LunarCrush subscription.

"Clot-Fighting Drug Plavix Set to Lose Patent Protection - The New York Times The drug which prevents clots among heart attack patients will no longer be promoted by Bristol-Myers Squibb because of an influx of cheaper generic alternatives"
News Link @nytimes 2025-09-29T20:09Z 52.9M followers, 78.8K engagements

Top Bristol-Myers Squibb Co Social Posts

Top posts by engagements in the last [--] hours

Showing a maximum of [--] top social posts without a LunarCrush subscription.

"Clean breakout play on $ATOM. Nearly +60% locked in. Try Everything Free for [--] Weeks 👉 $bmy $cmcsa $cpe $intc $pfe $slv $gme $pltr $mara $t $hood $clsk $snap https://bit.ly/XtradesSignals https://bit.ly/XtradesSignals"
X Link @TradingXtrades 2026-02-16T06:23Z [----] followers, [---] engagements

"$ABBV continues to hold strong with a fantastic weekly close. $XLV also continues to set up for a weekly breakout. Healthcare along with $AMGN and $BMY are all on watch for a continuation move. I think $ABBV can be a big runner if we break this DTL resistance. Over $240 can see $250+ quick. The resounding strength in $XLV despite the headwinds from $UNH is reason enough to add some healthcare names to your watchlist. $ABBV which is around 7% of $XLV is showing very structurally bullish price action. The earnings gap down gets swept at the [---] spot which was https://t.co/j0wj0qogYv The"
X Link @artisanwill12 2026-02-16T00:16Z [----] followers, [---] engagements

"NWBO StockTwits Buzz: Are Big Gains Hiding From You February [--] [----] by Emma Rose $nwbo $mrk $pfe $bmy $rhhby $lly $azn #dcvax https://tryhardguides.co.uk/nwbo-stocktwits https://tryhardguides.co.uk/nwbo-stocktwits"
X Link @sharpie510 2026-02-15T17:16Z [---] followers, [----] engagements

"Cartera actualizada tras los movimientos de la semana: Recorte del 32% en Bristol-Myers Squibb $BMY Recorte del 29% en Merck $MRK ❌ Venta de Procter & Gamble $PG"
X Link @AvutardaBolsa 2026-02-15T16:46Z [----] followers, [---] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing